MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
1.132 |
Evidence |
|
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
CIITA |
CIITA, MHC2TA: MHC class II transactivator |
1.132 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
MAPK10 |
MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 |
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
1.132 |
Evidence |
|
GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
1.132 |
Evidence |
|
GNAL |
GNAL: Guanine nucleotide-binding protein G(olf) subunit alpha |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
HLA-B |
HLA-B, HLAB: HLA class I histocompatibility antigen, B-7 alpha chain precursor |
AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
1.132 |
Evidence |
|
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.132 |
Evidence |
|
KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
LYN |
LYN: Tyrosine-protein kinase Lyn |
1.132 |
Evidence |
|
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
1.132 |
Evidence |
|
KCNB1 |
KCNB1: Potassium voltage-gated channel subfamily B member 1 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
1.132 |
Evidence |
|
KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
TRPV1 |
TRPV1: Vanilloid receptor variant TRPV1b |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
JAK1 |
|
1.132 |
Evidence |
|
IL3 |
IL3: Interleukin-3 precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
TRPV4 |
TRPV4, VRL2, VROAC: Transient receptor potential cation channel subfamily V memb |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
1.132 |
Evidence |
|
GNA14 |
GNA14: Guanine nucleotide-binding protein alpha-14 subunit |
CCR2 |
CCR2, CMKBR2: C-C chemokine receptor type 2 |
1.132 |
Evidence |
|
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
CASP8 |
CASP8, MCH5: Caspase-8 precursor |
1.132 |
Evidence |
|
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
1.132 |
Evidence |
|
CSH2 |
GH1: Somatotropin precursor |
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
1.132 |
Evidence |
|
TFAP4 |
TFAP4: Transcription factor AP-4 |
ID2 |
ID2: DNA-binding protein inhibitor ID-2 |
1.132 |
Evidence |
|
MMP9 |
MMP9, CLG4B: Matrix metalloproteinase-9 precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.132 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
1.132 |
Evidence |
|